Inventor · disambiguated record
Gebhard Thoma
Also filed as: THOMA GEBHARD
18 granted patents·11 pending applications·211 citations·filing 1996–2024
94Inventor score
Top patents by PatentIndex Score
29 records- 0195US8324225B2Pyrrolopyrimidine compounds and their usesBRAIN CHRISTOPHER THOMAS·Filed 2007·Granted Dec 4, 2012·45 cites·9 claims
- 0292US7671063B22,4 Di (hetero) -arylamino-pyrimidine derivatives as ZAP-70 and/or syk inhibitorsNOVARTIS AG·Filed 2006·Granted Mar 2, 2010·32 cites·9 claims
- 0391US11932630B2Heteroaryl aminopropanol derivativesNOVARTIS AG·Filed 2022·Granted Mar 19, 2024·2 cites·20 claims
- 0491US11708366B2Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereofNOVARTIS AG·Filed 2021·Granted Jul 25, 2023·2 cites·27 claims
- 0590US7666877B2Ergoline derivativesNOVARTIS AG·Filed 2006·Granted Feb 23, 2010·44 cites·4 claims
- 0683US9315500B2Bicyclic heteroaryl cycloalkyldiamine derivativesBUEHLMAYER PETER·Filed 2013·Granted Apr 19, 2016·10 cites·9 claims
- 0782US8283356B22,4- Di(hetero)-arylamino-pyrimidine derivatives as ZAP-70 and/or SYK inhibitorsBAENTELI ROLF·Filed 2010·Granted Oct 9, 2012·9 cites·11 claims
- 0879US7943627B22,4-diaminopyrimidine derivativesNOVARTIS AG·Filed 2003·Granted May 17, 2011·12 cites·4 claims
- 0979US2025092042A1Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereofNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1077US12157737B2Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereofNOVARTIS AG·Filed 2023·Granted Dec 3, 2024·0 cites·16 claims
- 1175US10570096B2Diamino pyridine derivativesNOVARTIS AG·Filed 2016·Granted Feb 25, 2020·1 cites·15 claims
- 1272US2024199593A1Novel Heteroaryl Aminopropanol DerivativesNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1371US8431589B22,4-diaminopyrimidine derivativesBAENTELI ROLF·Filed 2011·Granted Apr 30, 2013·2 cites·10 claims
- 1471US2022177432A1Novel diamino pyridine derivativesNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1568US6399071B1NeoglycoproteinsNOVARTIS AG·Filed 1998·Granted Jun 4, 2002·33 cites·12 claims
- 1667US11274080B2Diamino pyridine derivativesNOVARTIS AG·Filed 2020·Granted Mar 15, 2022·0 cites·8 claims
- 1765US7399771B2Piperidine derivatives as CCR5 inhibitorsNOVARTIS AG·Filed 2003·Granted Jul 15, 2008·3 cites·3 claims
- 1863US6677164B1Multivalent polymers, processes for their preparation, and their use for preparing biologically active compoundsNOVARTIS AG·Filed 1996·Granted Jan 13, 2004·14 cites·13 claims
- 1954US2008249111A1Piperdine Derivatives as CCR5 InhibitorsNOVARTIS AG·Filed 2008·Application pending·0 cites
- 2053US6723831B2NeoglycoproteinsNOVARTIS AG·Filed 2002·Granted Apr 20, 2004·2 cites·11 claims
- 2153US2013345180A12,4- diaminopyrimidine derivativesNOVARTIS AG·Filed 2013·Application pending·0 cites
- 2249US9290481B2Monocyclic heteroaryl cycloalkyldiamine derivativesSMITH ALEXANDER BAXTER·Filed 2013·Granted Mar 22, 2016·0 cites·6 claims
- 2349US2013310387A1Monocyclic Heteroaryl Cycloalkyldiamine DerivativesTHOMA GEBHARD·Filed 2013·Application pending·0 cites
- 2447US2012207763A1Pyrrolopyrimidine compounds and their usesBRAIN CHRISTOPHER THOMAS·Filed 2012·Application pending·0 cites
- 2541US2016213670A1Bicyclic heteroaryl cycloalkyldiamine derivatives as inhibitors of spleen tyrosine kinases (syk)NOVARTIS TIERGESUNDHEIT AG·Filed 2016·Application pending·0 cites
- 2640US2008234294A1Cxcr4 Binding MoleculesNOVARTIS AG·Filed 2006·Application pending·0 cites
- 2740US2010010025A1Pyrimidine DerivativesNORVARTIS AG·Filed 2007·Application pending·0 cites
- 2838US7671078B2Isothiourea derivatives of imadazo[2,1-b]Thiazoles and 5,6-dihydro derivatives thereof useful as CXCR4 chemokine receptor inhibitorsNOVARTIS AG·Filed 2005·Granted Mar 2, 2010·0 cites·7 claims
- 2936US2004142920A1Bipiperidinyl-derivatives and their use as chemokine receptors inhibitorsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gebhard Thoma files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →